1. Canada Stocks

  2. •

    Finance

  3. •

    Financial conglomerates
Neupath Health Inc.

Neupath Health Inc.

0.58
CAD
+0.01
(+1.75%)
0.03EPS
26.43P/E
35.90MMarket Cap
Nov 12Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.74
1.94
1.35
1.29
1.2
1.29
1.55
1.58
Basic EPS, GAAP
-0.19
-0.21
-0.07
-0.09
- -
-0.01
-0.01
0.02
Free Cash Flow per Basic Share
-0.04
-0.03
0.03
-0.02
0.05
0.03
0.06
0.04
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.34
0.66
0.55
0.43
0.39
0.38
0.37
0.4
Tangible Book Value per Share
-0.38
0.19
0.04
- -
0.01
- -
-0.01
0.03
Basic Weighted Avg Shares
29
24
45
48
55
56
56
56
Sales/Revenue/Turnover
50
48
61
63
66
73
87
89
Operating Margin (%)
-1.33
-1.72
-3.03
-2
0.67
1.94
2.34
2.68
Depreciation Expense
2
3
3
3
3
2
2
2
Net Income, GAAP
-5
-5
-3
-4
- -
-1
-1
1
Effective Tax Rate (%)
- -
- -
- -
- -
447.27
- -
- -
- -
Profit Margin (%)
-10.7
-10.62
-5.31
-6.61
-0.16
-1
-0.82
1.51
Working Capital
-9
9
2
-3
2
-4
1
2
LT Debt
10
8
12
10
11
4
11
11
Total Equity
10
28
26
22
22
21
21
23
Return on Invested Capital (%)
- -
- -
- -
- -
-9.6
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
-9.3
- -
- -
- -
Return on Common Equity (%)
- -
-27.05
-12.09
-17.41
-0.49
-3.35
-3.41
6.06

Capital Structure

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2
2
2
LT Borrowings
6
5
5
LT Finance Leases
6
6
6
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
56
56
57
Market Capitalization
27
26
36

Working Capital

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
14
14
14
Cash, Cash Equivalents & STI
4
4
4
Accounts Receivable, Net
9
9
10
Inventories
- -
- -
- -
Total Current Liabilities
13
12
12
Payables & Accruals
11
10
10
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-5.18%
-2.24%
Free Cash Flow
- -
-154.39%
89.27%
Net Income, GAAP
- -
94.72%
-1.51%
Sales/Revenue/Turnover
- -
13.22%
19.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
17
19
18
19
73
2025
19
24
22
22
87
2026
22
23
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
0.01
-0.01
- -
-0.01
2025
-0.01
- -
- -
-0.01
-0.01
2026
0.01
0.03
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Stephen L. Lemieux
Full Time Employees
211
Sector
Finance
Industry
Financial conglomerates
Address
Mississauga Canada
IPO Date
Dec 3, 2019
Website
neupath.com
Similar Companies
Strategy Inc (NASDAQ:MSTR)
BitMine Immersion Technologies, Inc. (NYSE:BMNR)
Strive, Inc. (NASDAQ:ASST)
Hyperliquid Strategies Inc (NASDAQ:PURR)
Stablecoin Development Corporation (AMEX:SDEV)
Greenland Energy Company (NASDAQ:GLND)
Business
NeuPath Health Inc. is a Canadian healthcare provider specializing in chronic pain management, spinal care, and musculoskeletal rehabilitation. Founded in 2017 and headquartered in Mississauga, Ontario, the company owns and operates an integrated network of interdisciplinary medical clinics across Ontario and Alberta. NeuPath Health delivers a comprehensive range of publicly insured and specialized private healthcare services, categorized into: multidisciplinary chronic pain assessment and multi-modal treatment plans, encompassing interventional pain procedures, nerve blocks, radiofrequency neurotomy, and pharmacotherapy management; specialized spinal, orthopedic, and sports medicine therapies; concussion assessment and post-trauma neuro-rehabilitation programs; virtual care and telemedicine consultations integrated alongside in-person clinical visits; independent medical evaluations (IMEs), functional capacity assessments, and occupational rehabilitation services for employers, disability insurers, and legal professionals; and contract clinical research services supporting clinical trials for pharmaceutical and biotechnology sponsors. The company operates its clinical facilities under several recognized brands, including Centers for Pain Management (CPM), HealthPointe Medical Centres, InMedic Creative Medicine, and the London Spine Institute. In recent major corporate developments, NeuPath Health expanded its clinical footprint by acquiring the assets of SIBI Medical Inc., operating as the London Spine Institute in London, Ontario, thereby broadening its specialized interventional spine care offerings. The company has also executed a comprehensive facilities optimization program aimed at consolidating clinic footprints into modern, capital-efficient centers, enhancing operational margins, scaling its blended digital-physical healthcare delivery model, and restructuring credit facilities to fund continuing strategic expansion across Canada.